~~<i id='0F352CA0E3'><strike id='0F352CA0E3'><tt id='0F352CA0E3'><pre id='0F352CA0E3'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：fashion 2025-09-28 16:43:24 Page View：76

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Climate activists disrupt London Pride march to protest corporate sponsorship
Next article： Tori Bowie and the unacceptable rates of Black maternal death

leisure time

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Russian court extends detention of American musician

2:12VIDEO:UScitizenarrestedinRussiaNTVAMoscowcourthasextendedthedetentionofTravisLeake,anAmericanman

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

9:34FormerPresidentDonaldTrumpspeaksduringarally,July7,2023,inCouncilBluffs,Iowa.CharlieRiedel/AP,FI